- Raffles Medical (SGX:BSL) released its 3Q22 Business Update, delivering another quarter of solid results as expected, in line with the strong 1H22 results. Raffles Medical's 3Q22 reported revenue growth of 6.5% y-o-y to S$199.5m while net profit surged by 62.1% y-o-y toS$38.3m. See Raffles Medical's announcement dated 31 Oct 2022. This is its first since the company moved to half-yearly reporting.
- - Read this at SGinvestors.io -
- - Read this at SGinvestors.io -
- Raffles Medical continues to expect foreign and local patients to return for treatment at its RafflesHospital, RafflesMedical, and RafflesDental branches. The potential reopening of China will also benefit RafflesChinaHealthcare.
- However, Raffles Medical highlights that slowing economic growth could dampen some high-end healthcare services, given the volatile macroeconomic environment.
Raffles Medical - Valuation & Recommendation
- Read more at SGinvestors.io.
Above is the excerpt from report by DBS Group Research.
Clients of DBS may access the full report in PDF @ https://www.dbs.com/insightsdirect/.
Rachel Lih Rui TAN DBS Group Research | https://www.dbs.com/insightsdirect/ 2022-11-01
Read also DBS's most recent report:
2023-11-07 Raffles Medical Group - Earnings Moderate Post Normalisation.
Previous report by DBS:
2023-02-28 Raffles Medical Group - Reaching A Near-Term Peak.
Price targets by 2 other brokers at Raffles Medical Target Prices.
Listing of research reports at Raffles Medical Analyst Reports.
Relevant links:
Raffles Medical Share Price History,
Raffles Medical Announcements,
Raffles Medical Dividends & Corporate Actions,
Raffles Medical News Articles